The World Health Organization approved the use of China’s Sinopharm Beijing Bio Vaccine (Sinopharm) this Friday. Reuters notes that the move provides a boost to Beijing authorities’ attempts to play a major role in global vaccination.
The two vaccines that China is currently reportedly exporting domestically and internationally include Sinopharm (Sinopharm) and Kexing (Sinovac). Among them, Sinopharm Beijing Bio Vaccine has become the only vaccine currently approved by WHO that is not developed in a Western country. And earlier this week, other WHO experts publicly expressed concerns about the reliability of the Chinese vaccine data and side effects.
Other new crown vaccines approved for use by the WHO to date include Pfizer, AstraZeneca, Johnson & Johnson and Modena.
WHO Director-General Desai Tan said Friday that the approved list of vaccines, in addition to being available for purchase under the 2019 New Coronavirus Vaccine Implementation Plan, provides confidence that countries have the autonomy to approve, import and vaccinate.
Recent Comments